Not really. 1 cent is not speculative and neither is an ind that wasn’t approved after 4 yrs of setting it up. Again these are facts and so is kw giving himself a raise to over a mill a yr. for a small biotech startup with 0 revenue. Also why didn’t we rise on submission. U know why. If pmcb gets a phase 2 with fda I’ll gladly say i overreacted. Let me ask u this. How can u defend kw and pmcb performance. We are a 1 cent with 2 and a half billion shares and the 1 shot we had never had a chance Which is why insiders dumped 10s of mill of shares after submission U make me wonder if u even have shares the way u ignore facts. Again 1 cent and an ind that wasn’t approved after 4 years of setting it up.
News 
Market Data 
Discover 
AI
